Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2019 Jan 25;19(1):44.
doi: 10.1186/s12888-019-2017-7.

Active contact and follow-up interventions to prevent repeat suicide attempts during high-risk periods among patients admitted to emergency departments for suicidal behavior: a systematic review and meta-analysis

Affiliations
Meta-Analysis

Active contact and follow-up interventions to prevent repeat suicide attempts during high-risk periods among patients admitted to emergency departments for suicidal behavior: a systematic review and meta-analysis

Masatoshi Inagaki et al. BMC Psychiatry. .

Abstract

Background: There is evidence that several intervention types, including psychotherapy, reduce repeat suicide attempts. However, these interventions are less applicable to the heterogeneous patients admitted to emergency departments (EDs). The risk of a repeat suicide attempt is especially high in the first 6 months after the initial attempt. Therefore, it is particularly important to develop effective ED interventions to prevent repeat suicide attempts during this 6-month period.

Methods: We systematically reviewed randomized controlled trials of ED-initiated interventions for suicidal patients admitted to EDs using the databases MEDLINE, PsychoINFO, CINAHL, and EMBASE up to January 2015 in accordance with an a priori published protocol (PROSPERO: CRD42013005463). Interventions were categorized into four types, including active contact and follow-up interventions (intensive care plus outreach, brief interventions and contact, letter/postcard, telephone, and composite of letter/postcard and telephone), and a meta-analysis was conducted to determine pooled relative risks (RRs) and 95% confidence intervals (CIs) of a repeat suicide attempt within 6 months.

Results: Of the 28 selected trials, 14 were active contact and follow-up interventions. Two of these trials (n = 984) reported results at 6 months (pooled RR = 0.48; 95% CI: 0.31 to 0.76). There were not enough trials of other interventions to perform meta-analysis. Some trials included in the meta-analysis were judged as showing risk of bias.

Conclusion: Active contact and follow-up interventions are recommended for suicidal patients admitted to an ED to prevent repeat suicide attempts during the highest-risk period of 6 months.

Systematic review registration: PROSPERO CRD42013005463 (27 August 2013).

Keywords: Emergency department; Meta-analysis; Self-harm; Suicide; Systematic review.

PubMed Disclaimer

Conflict of interest statement

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

MI has received lecture fees from Pfizer Japan Inc.; Mochida Pharmaceutical Co., Ltd.; Shionogi & Co., Ltd.; Sumitomo Dainippon Pharma Co., Ltd.; Daiichi Sankyo Co., Ltd.; Meiji Seika Pharma Co., Ltd.; and Takeda Pharmaceutical Co., Ltd. outside the submitted work. He has received royalties from Nippon Hyoron Sha Co., Ltd.; Nanzando Co., Ltd.; Seiwa Shoten Co., Ltd.; Igaku-shoin Ltd.; and Technomics, Inc. outside the submitted work. He has received grant or research support from the Japanese Ministry of Health, Labour and Welfare and the Japanese Ministry of Education, Science, and Technology. Dr. Inagaki’s institution has received grant or research support from Eisai Co., Ltd.; Mochida Pharmaceutical Co., Ltd.; Astellas Pharma Inc.; Otsuka Pharmaceutical Co., Ltd.; GlaxoSmithKline K. K.; Shionogi & Co.; Sumitomo Dainippon Pharma Co., Ltd.; Jansen Pharmaceutical K. K.; Pfizer Japan Inc.; MSD K. K.; Yoshitomiyakuhin Corporation; Daiichi Sankyo Co., Ltd.; Meiji Seika Pharma Co., Ltd.; Tsumura & Co.; AbbVie; Ono Pharmaceutical Co., Ltd.; and Eli Lilly Japan K. K. YK has received royalties from Seiwa Shoten Co., Ltd. outside the submitted work. He has received grants from Seseragi-Foundation and an Intramural Research Grant for Neurological and Psychiatric Disorders of National Center of Neurology and Psychiatry outside the submitted work. MY has received grant or research support from received grants from the Japan Agency for Medical Research and Development during the study; grants from the Ministry of Health, Labour and Welfare, Japan; grants from the Ministry of Education, Culture, Sports, Science and Technology, Japan; grants from The Japan Science and Technology Agency; grants from the National Center of Neurology and Psychiatry; personal fees from Meiji Seika Pharma Co., Ltd.; personal fees from MSD K.K.; personal fees from Asahi Kasei Pharma Corporation; personal fees from Seishin Shobo; personal fees from Seiwa Shoten Co., Ltd.; personal fees from Igaku-shoin Ltd.; personal fees from Chogai Igakusha; and personal fees from Sentan Igakusha. All other authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figures

Fig. 1
Fig. 1
Study selection. Two and 11 trials, respectively, were included in a meta-analysis of the effect of active contact and follow-up interventions on repeat suicide attempts at 6 and 12 months. There have been no new publications on psychotherapy and pharmacotherapy interventions for suicide attempts since our previous meta-analysis. Therefore, we did not perform meta-analyses on the effect of these interventions in the present study
Fig. 2
Fig. 2
Primary outcome: Suicide attempts within 6 months for active contact and follow-up interventions. Two trials of active contact and follow-up interventions reported suicide attempts within 6 months [41, 45]. Two trials were included in the meta-analysis [41, 45]. The number of included participants and the number of participants who made repeat suicide attempts in each trial are shown in Table 1. To assess heterogeneity, we used the Cochrane Q statistic to examine heterogeneity among the trials in each analysis. We regarded heterogeneity as substantial if the Cochrane Q test produced a low p-value (< 0.10)
Fig. 3
Fig. 3
Secondary Outcome: Suicide attempts within 12 months for active contact and follow-up interventions. a The meta-analysis included 11 trials [, , , , –, , –52]. The number of included participants and the number of participants who made repeat suicide attempts in each trial are shown in Table 1. To assess heterogeneity, we used the I2 and Cochrane Q statistics to examine heterogeneity among the trials in each analysis. We regarded heterogeneity as substantial if I2 was greater than 30% or if the Cochrane Q test produced a low p-value (< 0.10). b We investigated publication bias by constructing a funnel plot and by using the Egger test

References

    1. Christensen H, Cuijpers P, Reynolds CF., 3rd Changing the direction of suicide prevention research: a necessity for true population impact. JAMA Psychiatry. 2016;73(5):435–436. doi: 10.1001/jamapsychiatry.2016.0001. - DOI - PubMed
    1. World Health Organization. Health statistics and information system, Disease burden and mortality estimates. https://www.who.int/healthinfo/global_burden_disease/estimates/en/index1.... Accessed 12 Jan 2019.
    1. World Health Organization. Preventing suicide—a global imperative. http://apps.who.int/iris/bitstream/10665/131056/1/9789241564779_eng.pdf?.... Accessed 21 Apr 2016.
    1. Arias SA, Miller I, Camargo CA, Jr, Sullivan AF, Goldstein AB, Allen MH, Manton AP, Boudreaux ED. Factors associated with suicide outcomes 12 months after screening positive for suicide risk in the emergency department. Psychiatr Serv. 2016;67(2):206–213. doi: 10.1176/appi.ps.201400513. - DOI - PMC - PubMed
    1. Isometsa ET, Lonnqvist JK. Suicide attempts preceding completed suicide. Br J Psychiatry. 1998;173:531–535. doi: 10.1192/bjp.173.6.531. - DOI - PubMed

Publication types